Department of Cellular and Molecular Physiology, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania 10733
![]() |
ABSTRACT |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Induction of sepsis in rats causes an inhibition of protein synthesis in skeletal muscle that is resistant to the stimulatory actions of insulin. To gain a better understanding of the underlying reason for this lack of response, the present study was undertaken to investigate sepsis-induced alterations in insulin signaling to regulatory components of mRNA translation. Experiments were performed in perfused hindlimb preparations from rats 5 days after induction of a septic abscess. Sepsis resulted in a 50% reduction in protein synthesis in the gastrocnemius. Protein synthesis in muscles from septic rats, but not controls, was unresponsive to stimulation by insulin. The insulin-induced hyperphosphorylation response of the translation repressor protein 4E-binding protein 1 (4E-BP1) and of the 70-kDa S6 kinase (S6K1) (1), two targets of insulin action on mRNA translation, was unimpaired in gastrocnemius of septic rats. Hyperphosphorylation of 4E-BP1 in response to insulin resulted in its dissociation from the inactive eukaryotic initiation factor (eIF)4E · 4E-BP1 complex in both control and septic rats. However, assembly of the active eIF4F complex as assessed by the association of eIF4E with eIF4G did not follow the pattern predicted by the increased availability of eIF4E resulting from changes in the phosphorylation of 4E-BP1. Indeed, sepsis caused a dramatic reduction in the amount of eIF4G associated with eIF4E in the presence or absence of insulin. Thus the inability of insulin to stimulate protein synthesis during sepsis may be related to a defect in signaling to a step in translation initiation involved in assembly of an active eIF4F complex.
translation initiation; eukaryotic initiation factors 4G and 4E; 4E-binding protein 1; gastrocnemius; S6 kinase
![]() |
INTRODUCTION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
INSULIN RESISTANCE IN SKELETAL MUSCLE is one characteristic of the host's response to severe infection. Both glucose and protein metabolism in skeletal muscle show a diminished responsiveness to the anabolic actions of insulin during sepsis. With respect to protein metabolism, the ability of insulin to limit the release of amino acids from extrasplanchnic organs of septic rats is less than that observed in nonseptic rats (31). The release of amino acids from skeletal muscle during sepsis is dependent on a balance between rates of protein synthesis and protein degradation. Insulin is known to modulate both of these metabolic processes in various physiological and pathological conditions (for review see Refs. 4 and 21). Proteolysis in skeletal muscle consistently shows a relative resistance to inhibition by insulin during the immediate posttrauma period (30), acute (16-h) peritonitis (10, 11), or chronic bacteremia (33). Likewise, insulin fails to augment skeletal muscle protein synthesis after chronic (5-day) intra-abdominal sepsis (15).
The mechanisms through which insulin stimulates protein synthesis in
skeletal muscle are beginning to be elucidated. Insulin stimulates
protein synthesis, in part, by accelerating the rate of mRNA
translation. Two steps involved in translation initiation appear
important as major regulatory points in the overall control of protein
synthesis in vivo. The first is the binding of
met-tRNA
Insulin stimulates the mRNA binding step in translation initiation, in part, by enhancing the availability of eIF4E, which is modulated by its association with a small acid- and heat-labile protein, termed 4E-BP1 (PHAS-I) (19, 20). The interaction between 4E-BP1 and eIF4E is regulated by the extent of phosphorylation of 4E-BP1, which in turn is under control by insulin (19, 20, 22). Hypophosphorylated 4E-BP1 binds to eIF4E, sequestering the protein in an inactive 4E-BP1 · eIF4E complex. When eIF4E is bound to 4E-BP1, eIF4E binds to mRNA but cannot form an active eIF4E · eIF4G complex (23, 26), thereby preventing binding of mRNA to the ribosome. Insulin enhances the phosphorylation of 4E-BP1, thereby releasing eIF4E from the 4E-BP1 · eIF4E complex and allowing the eIF4E · mRNA complex to bind to eIF4G and then to the 43S preinitiation complex (23).
Insulin also acts on translation initiation, in part, by enhancing the activity of S6K1, a serine/threonine kinase that phosphorylates the ribosomal protein S6 (8). The ribosomal protein S6 is uniquely positioned to regulate translation of mRNA by its location at the tRNA binding site on the 40S ribosome. Increased phosphorylation of ribosomal S6 through activation of S6K1 correlates with accelerated rates of translation of mRNAs containing a 5'-terminal oligopyrimidine (TOP) sequence (12, 13). Activation of S6K1 by insulin correlates with hyperphosphorylation of the protein (9).
The present investigations were designed to examine the ability of insulin to modulate the phosphorylation status of both 4E-BP1 and S6K1 in the gastrocnemius of septic rats and to compare the response with that of controls by use of a perfused hindlimb preparation. The results indicate that insulin signaling to 4E-BP1 and S6K1 is relatively unimpaired in skeletal muscle of septic rats. In contrast, assembly of the active eIF4F complex, as measured by the interaction of eIF4E with eIF4G, was diminished in both the basal and insulin-stimulated conditions during sepsis. Thus a sepsis-induced defect in insulin signaling to mediate the assembly of the active eIF4F complex may account for the lack of action of the hormone on protein synthesis under these circumstances.
![]() |
EXPERIMENTAL PROCEDURES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Animals. Adult male Sprague-Dawley rats were maintained on a 12:12-h light-dark cycle. Rats weighing 200-300 g were anesthetized with a combination of ketamine (110 mg/kg body wt) and acepromazine (1 mg/kg body wt). Sepsis was then induced by implanting a sterilized fecal-agar pellet that was inoculated with 103 colony-forming units (CFU) Escerichia coli and 109 CFU Bacteroides fragilis into the abdominal cavity (5, 15, 16, 20, 31, 32, 38). The intra-abdominal septic abscess was allowed to develop for 5 days. Laparotomies were not performed in control rats. Previous studies provided evidence that rates of protein synthesis in skeletal muscle are not depressed 5 days after laparotomy or creation of a sterile abscess compared with muscle in nonoperated animals (15, 32, 38).
Hindlimb perfusion technique.
Hindlimb perfusions were carried out according to the method described
by Bylund-Fellenius et al. (3) as modified in our laboratory (15-17, 20). Five days after implantation
of the fecal-agar pellet, rats were anesthetized with pentobarbital
sodium (50 mg/kg body wt), and the skin covering the right and left
hindlimbs was removed. A midline incision was made, and both the
inferior vena cava and the abdominal aorta were exposed. The abdominal
aorta was cannulated, and perfusate was delivered immediately via the abdominal aorta at a rate of 0.32 ml · min1 · g
1
(3) to the hindlimb musculature. The inferior vena cava
was then cannulated. The first 50 ml of perfusate passing through the
hindlimb were discarded. The cannula in the inferior vena cava was then
connected to the perfusion system, and recirculation of the perfusate
was begun. After perfusion for an additional 35 min,
[3H]phenylalanine was introduced into the perfusate to
give a final concentration of 2 µCi/ml, and perfusion continued for
60 min. After perfusion, gastrocnemius muscles were frozen between
aluminum blocks precooled to the temperature of liquid nitrogen or used directly for analysis of eukaryotic initiation factors. A perfusate sample was withdrawn and centrifuged to remove red blood cells. The
perfusate plasma samples were stored at
20°C until analyzed for the
determination of phenylalanine specific radioactivity, as described
previously (15-17, 20).
Measurement of protein synthesis. Rates of protein synthesis were estimated by the incorporation of [3H]phenylalanine into muscle proteins (5, 15-17, 32, 33). Frozen tissue was powdered under liquid nitrogen. A portion (0.5 g) of powdered tissue was homogenized in 5 volumes of ice-cold 10% (wt/vol) trichloroacetic acid (TCA), and the homogenate was centrifuged at 10,000 g for 11 min at 4°C. The resulting supernatant was decanted, and the pellet was washed five times with 10% TCA to remove any acid-soluble radioactivity. After a wash with acetone and then with water, the pellet was dissolved in 0.1 N NaOH. Aliquots were assayed for protein using the Biuret method, with crystalline BSA serving as the protein standard. Another aliquot was assayed for radioactivity by liquid scintillation spectrometry with corrections for quenching (in dpm).
The rate of protein synthesis, expressed as nanomoles of phenylalanine incorporated into protein per hour per gram of muscle (nmol Phe · gDetermination of phosphorylation state of 4E-BP1. The various phosphorylated forms of 4E-BP1 were measured after immunoprecipitation of 4E-BP1 from muscle homogenates (19, 20). 4E-BP1 was immunoprecipitated from the supernatants as described previously (20, 35). The immunoprecipitates were solubilized with SDS sample buffer. The various phosphorylated forms of 4E-BP1 were separated by electrophoresis. After electrophoresis, the proteins were transferred electrophoretically onto polyvinylidene difluoride (PVDF) membranes. The membranes were incubated with polyclonal antibodies specific for 4E-BP1 for 1 h at room temperature. The blots were then developed using an enhanced chemiluminescence (ECL) Western blotting kit by following the manufacturer's instructions. Films were scanned using a Microtek ScanMaker III scanner equipped with a transparent media adapter connected to a Macintosh computer. Images were obtained using the ScanWizard Plugin (Microtek) for Adobe Photoshop, quantitated using National Institutes of Health Image 1.60 software and by protein immunoblot analysis as described previously (20, 22, 35).
Determination of phosphorylation state of S6K1. For determination of the phosphorylation state of S6K1, supernatants from a 10,000-g centrifugation were subjected to SDS-PAGE, transferred to PVDF membranes, and immunoblotted with a polyclonal antibody that recognizes S6K1 (Santa Cruz Biotechnology, Santa Cruz, CA) as described previously (1, 8). The blots were then developed using ECL. Films were scanned and quantitated as described previously (6, 34). There were no significant differences in the amount of SK61 in muscles from septic rats [146 ± 18 arbitrary units (AU)/mg protein; n = 9] compared with control animals (127 ± 18 AU/mg protein; n = 10).
Quantification of 4E-BP1 · eIF4E and
eIF4G · eIF4E complexes.
The association of eIF4E with 4E-BP1 and eIF4G was determined as
described previously (29). Briefly, hindlimb muscles were rapidly removed, immediately weighed, and homogenized in 7 volumes of
buffer A [20 mM HEPES, pH 7.4, 100 mM KCl, 0.2 mM EDTA, 2 mM EGTA, 1 mM dithiothreitol, 50 mM NaF, 50 mM -glycerolphosphate, 0.1 mM phenylmethylsulfonyl fluoride (PMSF), 1 mM benzamidine, 0.5 mM
sodium vanadate, and 1 µM microcystin LR] with a Polytron homogenizer. The homogenate was centrifuged at 10,000 g for
10 min at 4°C. eIF4E and 4E-BP1 · eIF4E and
eIF4G · eIF4E complexes were immunoprecipitated from aliquots
of 10,000-g supernatants with an anti-eIF4E monoclonal
antibody. The antibody/antigen complex was collected by incubation for
1 h with goat anti-mouse Biomag IgG beads (PerSeptive
Diagnostics). Before use, the beads were washed in 1% nonfat dry milk
in buffer B (50 mM Tris · HCl, pH 7.4, 150 mM NaCl,
5 mM EDTA, 0.1%
-mercaptoethanol, 0.5% Triton X-100, 50 mM NaF, 50 mM
-glycerolphosphate, 0.1 mM PMSF, 1 mM benzamidine, and 0.5 mM
sodium vanadate). The beads were captured using a magnetic stand and
were washed twice with buffer B and once with buffer
B containing 500 mM NaCl rather than 150 mM NaCl. Resuspending the
beads in SDS-sample buffer and boiling the sample for 5 min eluted
protein bound to the beads. The beads were collected by centrifugation,
and the supernatants were subjected to electrophoresis, either on a
10% polyacrylamide gel for quantitation of eIF4G or on a 15%
polyacrylamide gel for quantitation of 4E-BP1 and eIF4E. Proteins were
then electrophoretically transferred to a PVDF membrane, as described
previously (19, 20). The membranes were incubated with a
mouse anti-human eIF4E antibody, a rabbit anti-rat 4E-BP1 antibody, or
a rabbit anti-eIF4G antibody for 1 h at room temperature. The
blots were then developed using an ECL Western blotting kit by
following the manufacturer's instructions. Films were scanned and
quantitated as described in Determination of phosphorylation state of 4E-BP1.
Determination of eIF4E phosphorylation state. The phosphorylated and unphosphorylated forms of eIF4E in extracts of hindlimb muscles were separated by isoelectric focusing on a slab gel and quantitated by protein immunoblot analysis, as described previously (19, 20, 29).
Statistical analysis. Values shown are means ± SE. Statistical evaluation of the data was performed using analysis of variance (ANOVA) to test for overall differences among groups, followed by the Sidak test for multiple comparisons to determine significance between means only when ANOVA indicated a significant difference among the group means. Differences among the means were considered significant when P was <0.05.
![]() |
RESULTS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Protein synthesis. The effect of insulin on protein synthesis in gastrocnemius muscle during sepsis was studied using the isolated perfused hindlimb. The use of the perfused hindlimb preparation allows for the direct examination of the effects of insulin on the regulation of translation initiation in muscle independent of alterations in other hormones and/or metabolites that occur in vivo. The gastrocnemius was chosen because previous studies have established that protein synthesis is regulated differently in various muscle types during sepsis (38). Sepsis causes an inhibition of protein synthesis in muscle composed primarily of fast-twitch fibers (i.e., gastrocnemius, psoas), whereas in muscles composed of slow-twitch fibers (i.e., soleus), protein synthesis is unaffected (4, 5, 38). More importantly, insulin fails to stimulate protein synthesis in perfused gastrocnemius of septic rats (15).
The stimulatory effect of insulin on protein synthesis in gastrocnemius from control, fed rats was confirmed (Fig. 1). Insulin at a concentration of 100 µU/ml stimulated protein synthesis ~50% compared with muscle perfused in the absence of the hormone, when physiological concentrations of amino acids were provided (P < 0.05). Protein synthesis was reduced in gastrocnemius from septic rats in both the basal and insulin-stimulated conditions compared with controls. In the basal state, protein synthesis was reduced to ~50% of control values in gastrocnemius from septic rats (P < 0.05). In contrast to control animals, insulin failed to significantly stimulate protein synthesis in gastrocnemius of septic rats. Moreover, the rate of protein synthesis in gastrocnemius of septic rats treated with insulin remained significantly (P < 0.05) less than that observed in control muscle.
|
4E-BP1 phosphorylation.
One explanation for the failure of insulin to stimulate protein
synthesis in gastrocnemius of septic rats would be that there is a
general defect in insulin signaling. 4E-BP1 undergoes multiple phosphorylations, which are characterized by reduced mobility during
electrophoresis. 4E-BP1 is resolved into multiple electrophoretic forms
termed ,
, and
, representing differently phosphorylated forms
of the protein (23, 26). In control rats, insulin augments the abundance of the most highly phosphorylated form of the protein, 4E-BP1
(23, 26). Therefore, we investigated the effects
of sepsis and insulin on the abundance of 4E-BP1
(Fig.
2). Under basal conditions, sepsis
induced a 50% decrease in the proportion of 4E-BP1 in the
-form.
Insulin caused a significant increase in the abundance of 4E-BP1
in
muscles from both control and septic rats. There were no significant
differences in the proportion of 4E-BP1 in the
-form in
insulin-treated muscles between control (55 ± 7%) and septic
rats (63 ± 3%). Thus insulin signaling to 4E-BP1 appears
unimpaired in sepsis.
|
Phosphorylation of S6K1.
Insulin also activates S6K1. Like 4E-BP1, S6K1 is activated by
multisite phosphorylation that results in hyperphosphorylated forms of
the protein. When subjected to SDS-PAGE, S6K1 resolves into multiple
electrophoretic forms (for review see Ref. 9), with
increased phosphorylation corresponding to a reduced electrophoretic mobility. The slowest migrating form represents S6K1 phosphorylated on
multiple residues including Thr389, a residue whose
phosphorylation is associated with activation of the protein
(41). We used this property (assessed by immunoblotting techniques) as an indicator of the effect of insulin on the activation of S6K1 in perfused skeletal muscle from control and septic rats. Perfusion with buffer containing insulin enhanced the prominence of the
more electrophoretically retarded bands in skeletal muscles from both
control and septic rats treated with insulin (Fig.
3). The percentage of S6K1 in the most
phosphorylated form was significantly elevated in gastrocnemius
perfused in the presence of insulin from either control [+Insulin:
11 ± 3% (n = 5) vs. Insulin: 0.19 ± 0.19% (n = 5); P < 0.05] or septic
[+Insulin: 24 ± 6% (n = 4) vs.
Insulin:
0 ± 0% (n = 4); P < 0.01]
compared with values obtained in muscles perfused in the absence of the
hormone (Fig. 3). Likewise, the percentage of S6K1 in the least
phosphorylated form was significantly reduced in gastrocnemius perfused
in the presence of insulin from either control [+Insulin: 15 ± 3% (n = 5) vs.
Insulin: 61 ± 9% (n = 5); P < 0.05] or septic
[+Insulin: 7 ± 2% (n = 4) vs.
Insulin: 53 ± 13% (n = 4); P < 0.01]
compared with values obtained in muscles perfused in the absence of the
hormone. These observations indicate a net increase in the
phosphorylation state of the protein from either control or septic
rats. Thus insulin signaling to S6K1 also appears unimpaired in sepsis.
|
Regulation of eIF4F complex assembly.
Insulin administration has been proposed to stimulate global rates of
protein synthesis by enhancing the assembly of the active eIF4F complex
through increased availability of eIF4E (19, 20, 22). The
changes in the extent of phosphorylation of 4E-BP1 would be expected
to modulate the association of 4E-BP1 with eIF4E in sepsis and after
insulin treatment. Therefore, we examined whether eIF4E availability
for eIF4F complex assembly was increased to a similar extent after
stimulation by insulin in control or septic rats. To investigate this
possibility, eIF4E immunoprecipitates were analyzed for 4E-BP1 content
(Fig. 4). The relative amount of 4E-BP1
was normalized by dividing the values for 4E-BP1 by the amount of eIF4E
present in the immunoprecipitate. As shown in Fig. 4, an increased
association of 4E-BP1 with eIF4E was observed in muscles from septic
rats compared with controls. Perfusion with insulin resulted in a
reduction in the amount of 4E-BP1 bound to eIF4E in both control and
septic rats. There were no significant differences in the amount of
4E-BP1 bound to eIF4E in septic rats perfused with insulin compared
with controls perfused with insulin. In addition, the differences in
association of 4E-BP1 with eIF4E were not the result of significant
differences in the amounts of 4E-BP1 [Control = 3,127 ± 258 arbitrary units (n = 10); Septic = 3,794 ± 242 arbitrary units (n = 9)] between the two groups.
|
|
|
eIF4E phosphorylation.
To further define potential mechanisms responsible for the
sepsis-induced inhibition of protein synthesis, the effect of sepsis on
phosphorylation of eIF4E was examined (Fig.
7). In these studies, slab gel
isoelectric focusing was used to separate phosphorylated and
nonphosphorylated forms of eIF4E, followed by immunoblot analysis to
quantitate the amount of eIF4E in the two forms. In muscles from
control rats, ~85% of eIF4E was in the phosphorylated form. Neither
insulin nor sepsis significantly affected the proportion of eIF4E in
the phosphorylated form. Therefore, it is unlikely that the failure of
insulin to augment rates of protein synthesis during sepsis occurred as
a result of alterations in the phosphorylation state of eIF4E.
|
![]() |
DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
We have previously established that chronic (5-day) sepsis causes a reduction in global rates of protein synthesis in skeletal muscle (15-17, 32, 38) that results from decreased translation initiation (15, 36, 38-40). It has been suggested that one way to augment protein synthesis during sepsis would be through administering anabolic hormones. Insulin enhances protein synthesis in skeletal muscle of nonseptic rats through an acceleration of translation initiation (for review see Refs. 4 and 21). For example, decreased rates of protein synthesis secondary to fasting or diabetes can be stimulated by provision of insulin in both rat heart (14) and skeletal muscle (18, 19). Despite the ability of insulin to increase protein synthesis in a variety of conditions, skeletal muscle from septic animals shows a relative resistance to the anabolic effects of the hormone on protein synthesis (15). The response of protein synthesis to increasing insulin concentrations in the gastrocnemius of septic rats is characterized by both a decreased sensitivity and a decreased maximal responsiveness compared with control rats (15). The potential mechanism for the failure of insulin to enhance translation initiation in muscles from septic rats has not been elucidated.
A general defect in insulin signaling would be one explanation for the
failure of insulin to stimulate protein synthesis in skeletal muscle of
septic animals. In nonseptic rats, insulin induces the phosphorylation
of 4E-BP1 (19, 20, 29). Hence, functional insulin
signaling in skeletal muscle from septic rats perfused with the hormone
should be associated with an increase in the extent of phosphorylation
of 4E-BP1. In both control and septic animals, insulin caused a marked
increase in the proportion of 4E-BP1 in the -phosphorylated form to
a similar extent. The insulin-induced stimulation of 4E-BP1
phosphorylation is thought to occur after activation of the
phosphatidylinositol 3-kinase pathway through increased activity of a
protein kinase termed the mammalian target of rapamycin (mTOR). The
results of the present set of experiments suggest that insulin
signaling through mTOR activity is maintained in septic rats.
S6K1 is a serine/threonine kinase that phosphorylates the ribosomal protein S6, and it has been implicated in stimulating skeletal muscle protein synthesis after insulin treatment (8). Insulin stimulates the activity of S6K1 and results in multisite phosphorylation of the protein (9). It is currently thought that phosphorylation of S6K1, like that of 4E-BP1, lies distal to mTOR in the signaling pathway for insulin. Hence, stimuli that affect the activity of mTOR should influence the extent of phosphorylation of both S6K1 and 4E-BP1. Because the phosphorylation of 4E-BP1 was enhanced to a similar extent after stimulation with insulin in control and septic rats, we also examined the extent of phosphorylation of S6K1. In muscles from both control and septic rats, insulin caused an increased phosphorylation of S6K1. Thus the insulin-signaling pathway leading to enhanced phosphorylation of both S6K1 and 4E-BP1, presumably through mTOR, is activated by insulin in muscles from septic rats despite a failure of the hormone to augment protein synthesis.
Anabolic hormones, such as insulin or insulin-like growth factor I, stimulate global rates of protein synthesis in skeletal muscle, in part, through changes in the regulation of eIF4F (20, 35). eIF4F is a protein complex composed of eIF4E, the 7-methyl-GTP cap-binding protein, and eIF4G, a scaffold protein with binding sites for other proteins, including eIF4E and the third component of eIF4F, the ATP-dependent helicase eIF4A. The translation of mRNA involves recruitment of the mRNA to the 43S preinitiation ribosomal subunit. The efficacy of the mRNA binding to the ribosome may be controlled through the distribution of eIF4E between active eIF4E · eIF4G and inactive eIF4E · 4E-BP1 complexes (19, 20, 22, 36). When eIF4E is bound to 4E-BP1, eIF4E binds to mRNA but cannot form an active eIF4E · eIF4G complex (for review see Refs. 4 and 27). In this scenario, formation of the 4E-BP1 · eIF4E complex prevents binding of mRNA to the ribosome. Insulin causes release of eIF4E from 4E-BP1 and promotes the assembly of the active eIF4E · eIF4G complex (19, 20). Therefore, it might be expected that modulation of eIF4E distribution between the active eIF4E · eIF4G complex and inactive eIF4E · 4E-BP1 complex would contribute to the failure of insulin to stimulate protein synthesis in skeletal muscle during sepsis.
In the present set of experiments, insulin caused an increase in the abundance of eIF4G bound to eIF4E compared with the basal state in muscles from both control and septic rats. The amount of eIF4G bound to eIF4E in muscles from septic rats perfused with insulin was approximately the same as was observed in controls in the basal condition and 50% of that observed in controls treated with insulin. Thus insulin failed to raise the amount of eIF4G bound to eIF4E to values observed in skeletal muscle from control animals treated with insulin. These findings indicate that sepsis prevents insulin from enhancing the association of eIF4E to eIF4G to the same extent as controls.
One potential mechanism to account for the inability of insulin to increase the amount of eIF4E bound to eIF4G would be through a failure of eIF4E to be released from the inactive 4E-BP1 · eIF4E complex. Addition of insulin to the perfusion buffer diminished the abundance of 4E-BP1 associated with eIF4E to a similar extent in muscles from both control and septic rats. The decrease in the amount of 4E-BP1 associated with eIF4E after insulin was inversely correlated with increases in the extent of 4E-BP1 phosphorylation. Thus insulin induced a marked reduction in the binding of eIF4E to 4E-BP1 to the same extent in control and septic rats, presumably by freeing eIF4E for binding to eIF4G. However, although eIF4E binding to 4E-BP1 was reduced in muscles from septic rats treated with insulin, formation of the eIF4E · eIF4G complex was not restored to values observed in control rats perfused with insulin. Thus, in muscles from septic rats, association of eIF4E with 4E-BP1 accounts for only a portion of the change in eIF4F assembly. Moreover, the results suggest that additional mechanisms must be operative to repress eIF4E binding to eIF4G during sepsis.
For a given amount of eIF4G bound to eIF4E (Fig. 6) or enhanced phosphorylation of S6K1 in muscles from septic animals perfused with insulin, the rate of protein synthesis was reduced compared with that of controls. Several possible scenarios can be hypothesized to account for this finding. First, the changes in eIF4E binding to eIF4G may be associated with altered translation of specific mRNAs during sepsis. Enhanced formation of the eIF4E · eIF4G complex in cells in culture results in the preferential stimulation in the synthesis of specific proteins (e.g., ornithine decarboxylase or myc) encoded by mRNAs that typically contain a high degree of secondary structure in the 5'-untranslated region. These proteins may reflect only a small percentage of the proteins synthesized, and, hence, an accelerated rate of translation of mRNAs encoding for these proteins would not be of significant magnitude to augment global rates of protein synthesis. Likewise, phosphorylation of S6K1 enhances synthesis of proteins whose mRNAs contain an oligopyrimidine tract in the 5' terminus (TOP mRNAs). These proteins include elongation factors and ribosomal proteins. In support of this scenario, inactivation of S6K1 caused by inhibition of mTOR with rapamycin results in only a modest decrease in the global rate of protein synthesis in skeletal muscles after treatment with insulin (7, 8). These findings indicate that much of the stimulatory effect of insulin on global rates of protein synthesis in skeletal muscle may be independent of rapamycin-sensitive pathways (7, 8). More importantly, the data suggest that sepsis modulates an mTOR-independent pathway, limiting not only protein synthesis in the basal condition but also the ability of insulin to stimulate the process.
Second, sepsis may induce modifications in eIF4G or other proteins that render the protein less likely to bind to eIF4E. For example, incubation of 293T cells with serum induces phosphorylation of eIF4G (28). In addition to phosphorylation, eIF4G can be cleaved by several proteases, including caspase 3 (2, 24) and calpains (25). There may also be unknown proteins induced or activated during sepsis that interact with eIF4G to prevent the ability of eIF4G to bind with eIF4E. However, whether any of these potential changes modulates the ability of eIF4G to initiate translation remains to be determined.
Third, we have previously reported that formation of the 43S
preinitiation complex is markedly reduced in skeletal muscle during
sepsis (38-40). Furthermore, the decreased formation
of the 43S preinitiation complex is associated with a diminished activity and expression of eIF2B during chronic sepsis (37, 39,
40). Thus a reduced amount of eIF2B protein may limit translation initiation and, hence, protein synthesis in the
gastrocnemius during sepsis (6, 39, 40). In the present
set of experiments, the abundance of eIF2B was reduced by ~40% in
muscles from septic rats perfused under basal conditions without
insulin present, as assessed by Western blot techniques. Perfusion of
muscles from either control or septic rats with insulin present in the
buffer did not cause the amount of eIF2B to be increased, as expected from such a short time of exposure to the hormone (data not shown). Therefore, the abundance of eIF2B remained significantly lower in
gastrocnemius from septic rats compared with controls after perfusion
with buffer containing insulin (P < 0.01; ANOVA
F = 14.49, P < 0.0001). The changes in the
expression of eIF2B were consistent with the alterations in protein
synthesis under the different experimental conditions. Thus the failure
of insulin to stimulate protein synthesis even though the amount of
eIF4E bound to eIF4G is increased may be related to a block at the
level of eIF2B.
![]() |
ACKNOWLEDGEMENTS |
---|
This work was supported by National Institute of General Medical Sciences Grant GM-39277 (T. C. Vary) and National Institute of Diabetes and Digestive and Kidney Diseases Grant DK-15658 (L. S. Jefferson).
![]() |
FOOTNOTES |
---|
Address for reprint requests and other correspondence: T. C. Vary, Dept. of Cellular and Molecular Physiology, The Pennsylvania State Univ. College of Medicine, Hershey, PA 10733 (E-mail: TVARY{at}psu.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 19 January 2001; accepted in final form 12 July 2001.
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
1.
Anthony, JC,
Gautsch T,
Kimball SR,
Vary TC,
and
Jefferson LS.
Orally administered leucine stimulates protein synthesis in skeletal muscle of postabsorptive rats in association with increased eIF4F formation.
J Nutr
130:
139-145,
2000
2.
Bushell, M,
McKendrick L,
Janicke RU,
Clemens MJ,
and
Morley SJ.
Caspase-3 is necessary and sufficient for cleavage of protein synthesis eukaryotic factor 4G during apoptosis.
FEBS Lett
451:
332-336,
1999[ISI][Medline].
3.
Bylund-Fellenius, AC,
Ojamaa KM,
Flaim KE,
Li JB,
Wassner SJ,
and
Jefferson LS.
Protein synthesis versus energy state in contracting muscles of perfused rat hindlimb.
Am J Physiol Endocrinol Metab
246:
E297-E305,
1984
4.
Cooney, RN,
Kimball SR,
and
Vary TC.
Regulation of skeletal muscle protein turnover during sepsis: mechanisms and mediators.
Shock
7:
1-16,
1998[ISI].
5.
Cooney, R,
Owens E,
Jurasinski C,
Gray K,
Vannice J,
and
Vary T.
Interleukin-1 receptor antagonist prevents sepsis-induced inhibition of protein synthesis.
Am J Physiol Endocrinol Metab
267:
E636-E641,
1994.
6.
Cooney, R,
Kimball SR,
Eckman R,
Maish G, III,
Shumate M,
and
Vary TC.
TNF-binding protein ameliorates inhibition of skeletal muscle protein synthesis during sepsis.
Am J Physiol Endocrinol Metab
276:
E611-E619,
1999
7.
Dardevet, D,
Sornet C,
and
Grizard J.
Glucocorticoid-induced insulin resistance of protein synthesis is independent of rapamycin-sensitive pathways in rat skeletal muscle.
J Endocrinol
162:
77-85,
1999
8.
Dardevet, D,
Sornet C,
Vary T,
and
Grizard J.
Phosphatidylinositol 3-phosphate and p70 S6 kinase participate in the regulation of protein turnover in skeletal muscle by insulin and insulin-like growth factor-I.
Endocrinology
134:
4089-4094,
1996.
9.
Farrari, S,
and
Thomas G.
S6 phosphorylation and the p70(s6k)/p85(s6k).
Crit Rev Biochem Mol Biol
29:
385-413,
1994[Abstract].
10.
Hasselgren, PO,
James JH,
Benson DW,
Hall-Angeras M,
Angeras U,
Hiyama DT,
Li S,
and
Fischer JE.
Total and myofibrillar protein breakdown in different types of rat skeletal muscle: effects of sepsis and regulation by insulin.
Metabolism
38:
6334-6340,
1989.
11.
Hasselgren, PO,
Warner BW,
James JH,
Takehara H,
and
Fischer JE.
Effect of insulin on amino acid uptake and protein turnover in skeletal muscle from septic rats. Evidence for insulin resistance of protein breakdown.
Arch Surg
122:
228-233,
1987[Abstract].
12.
Jefferies, HB,
Fumagalli S,
Dennis P,
Reinhard C,
Pearson R,
and
Thomas G.
Rapamycin suppresses 5'TOP mRNA translation through inhibition of p70s6k.
EMBO J
16:
3693-3704,
1997
13.
Jefferies, HB,
Reinhard C,
Kozma SC,
and
Thomas G.
Rapamycin selectively represses translation of the "polypyrimidine tract" mRNA family.
Proc Natl Acad Sci USA
91:
4441-4445,
1994[Abstract].
14.
Jefferson, LS,
Rannels DE,
Munger BJ,
and
Morgan HE.
Insulin in the regulation of protein turnover in heart and skeletal muscle.
Fed Proc
33:
1098-1104,
1974[ISI][Medline].
15.
Jurasinski, C,
Gray K,
and
Vary TC.
Modulation of skeletal muscle protein synthesis by amino acids and insulin during sepsis.
Metabolism
44:
1130-1138,
1995[ISI][Medline].
16.
Jurasinski, CV,
Kilpatrick L,
and
Vary TC.
Amrinone prevents muscle protein wasting during chronic sepsis.
Am J Physiol Endocrinol Metab
268:
E491-E500,
1995
17.
Jurasinski, CV,
and
Vary TC.
Insulin-like growth factor I accelerates protein synthesis in skeletal muscle during sepsis.
Am J Physiol Endocrinol Metab
269:
E977-E981,
1995
18.
Kimball, S,
and
Jefferson L.
Effect of diabetes on guanine nucleotide exchange factor activity in skeletal muscle and heart.
Biochem Biophys Res Comm
156:
706-711,
1988[ISI][Medline].
19.
Kimball, SR,
Jefferson LS,
Fadden P,
Haystead TAJ,
and
Lawrence JC, Jr.
Insulin and diabetes cause reciprocal changes in the association of eIF-4E and PHAS-I in rat skeletal muscle.
Am J Physiol Cell Physiol
270:
C705-C709,
1996
20.
Kimball, SR,
Jurasinski CV,
Lawrence JC, Jr,
and
Jefferson LS.
Insulin stimulates protein synthesis in skeletal muscle by enhancing the association of eIF-4E and eIF-4G.
Am J Physiol Cell Physiol
272:
C754-C759,
1997
21.
Kimball, SR,
Vary TC,
and
Jefferson LS.
Regulation of protein synthesis by insulin.
Ann Rev Physiol
56:
321-348,
1994[ISI][Medline].
22.
Kimball, SR,
Horetsky RL,
and
Jefferson LS.
Signal transduction pathways involved in the regulation of protein synthesis by insulin in L6 myoblasts.
Am J Physiol Cell Physiol
274:
C221-C228,
1998
23.
Lin, T,
Kong X,
Haystead T,
Pause A,
Belsham G,
Sonnenberg N,
and
Lawrence J.
PHAS-I as a link between mitogen activated protein kinase and translation initiation.
Science
266:
653-656,
1994[ISI][Medline].
24.
Morley, SJ,
McKendrick L,
and
Bushell M.
Cleavage of translation initiation factor 4G (eIF4G) during anti-Fas IgM-induced apoptosis does not require signalling through the p38 mitogen-activated protein (MAP) kinase.
FEBS Lett
438:
41-48,
1998[ISI][Medline].
25.
Neumar, RW,
DeGracia DJ,
Konkoly LL,
Khoury JL,
White BC,
and
Krause GS.
Calpain mediates eukayrotic initiation factor 4G degradation during global ischemia.
J Cerebral Blood Flow Metab
18:
876-881,
1998[ISI][Medline].
26.
Pause, A,
Belsham GJ,
Gingras AC,
Donze O,
Lin TA,
Lawrence JC, Jr,
and
Sonenberg N.
Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5'-cap function.
Nature
371:
762-767,
1994[ISI][Medline].
27.
Raught, B,
and
Gingras AC.
eIF4E activity is regulated at multiple levels.
Int J Biochem Cell Biol
31:
43-57,
1999[ISI][Medline].
28.
Raught, B,
Gingras AC,
Gygi SP,
Imaataka H,
Morino S,
Gradi A,
Aebersold R,
and
Sonenberg N.
Serum-stimulated, rapamycin-sensitive phosphorylation sites in eukaryotic translation initiation factor 4GI.
EMBO J
19:
434-444,
2000
29.
Svanberg, E,
Jefferson LS,
Lundholm K,
and
Kimball SR.
Postprandial stimulation of muscle protein synthesis is independent of changes in insulin.
Am J Physiol Endocrinol Metab
272:
E841-E847,
1997
30.
Tischler, M,
and
Fagan J.
Response to trauma and protein, amino acid, and carbohydrate metabolism in injured and uninjured rat skeletal muscle.
Metabolism
32:
853-868,
1983[ISI][Medline].
31.
Vary, TC,
and
Murphy JM.
Role of extrasplanchnic organs in the metabolic response to sepsis: effect of insulin.
Circ Shock
29:
41-57,
1989[ISI][Medline].
32.
Vary, TC,
Siegel JH,
Tall DH,
Morris JG,
and
Smith JA.
Inhibition of skeletal muscle protein synthesis in septic intraabominal abscess.
J Trauma
28:
981-988,
1988[ISI][Medline].
33.
Vary, TC,
Dardevet D,
Grizard J,
Voisin L,
Buffiere C,
Denis P,
Breuille D,
and
Obled C.
Differential regulation of skeletal muscle protein turnover by insulin and IGF-I after bacteremia.
Am J Physiol Endocrinol Metab
275:
E584-E593,
1998
34.
Vary, TC,
Jefferson LS,
and
Kimball SR.
Amino acid-induced stimulation of translation initiation in rat skeletal muscle.
Am J Physiol Endocrinol Metabol
277:
E1077-E1086,
1999
35.
Vary, TC,
Jefferson LS,
and
Kimball SR.
Role of eIF4E in stimulation of protein synthesis by IGF-I in perfused rat skeletal muscle.
Am J Physiol Endocrinol Metab
278:
E58-E64,
2000
36.
Vary, TC,
Jurasinski CV,
Karinch AM,
and
Kimball SR.
Regulation of eukaryotic initiation factor-2 expression during sepsis.
Am J Physiol Endocrinol Metab
266:
E193-E201,
1994
37.
Vary, TC,
Jurasinski CV,
and
Kimball SR.
Reduced 40S initiation complex formation in skeletal muscle during sepsis.
Mol Cell Biochem
178:
81-86,
1998[ISI][Medline].
38.
Vary, TC,
and
Kimball SR.
Sepsis-induced changes in protein synthesis: differential effects on fast- and slow-twitch muscles.
Am J Physiol Cell Physiol
262:
C1513-C1519,
1992
39.
Vary, TC,
Voisin L,
and
Cooney RN.
Regulation of peptide-chain initiation in muscle during sepsis by interleukin-1 receptor antagonist.
Am J Physiol Endocrinol Metab
271:
E513-E520,
1996
40.
Voisin, L,
Gray K,
Flowers KM,
Kimball SR,
Jefferson LS,
and
Vary TC.
Altered expression of eukaryotic initiation factor 2B in skeletal muscle during sepsis.
Am J Physiol Endocrinol Metab
270:
E43-E50,
1996
41.
Weng, QP,
Kozlowski M,
Belham C,
Zhang A,
Comb MJ,
and
Avruch J.
Regulation of the p70 S6 kinase by phosphorylation in vivo: analysis using site-specific anti-phosphopeptide antibodies.
J Biol Chem
273:
16621-16629,
1998